148 related articles for article (PubMed ID: 38110824)
1. Biosensors based on potent miniprotein binder for sensitive testing of SARS-CoV‑2 variants of concern.
Hao L; Li X; Liang H; Lei W; Yang W; Zhang B
Mikrochim Acta; 2023 Dec; 191(1):38. PubMed ID: 38110824
[TBL] [Abstract][Full Text] [Related]
2. A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern.
Yuan M; Chen X; Zhu Y; Dong X; Liu Y; Qian Z; Ye L; Liu P
J Virol; 2022 Aug; 96(16):e0077522. PubMed ID: 35916510
[TBL] [Abstract][Full Text] [Related]
3. Peptide Binder with High-Affinity for the SARS-CoV-2 Spike Receptor-Binding Domain.
Yu L; Wang R; Wen T; Liu L; Wang T; Liu S; Xu H; Wang C
ACS Appl Mater Interfaces; 2022 Jun; 14(25):28527-28536. PubMed ID: 35713340
[TBL] [Abstract][Full Text] [Related]
4. Quantum dots assembly enhanced and dual-antigen sandwich structured lateral flow immunoassay of SARS-CoV-2 antibody with simultaneously high sensitivity and specificity.
Jia J; Ao L; Luo Y; Liao T; Huang L; Zhuo D; Jiang C; Wang J; Hu J
Biosens Bioelectron; 2022 Feb; 198():113810. PubMed ID: 34840014
[TBL] [Abstract][Full Text] [Related]
5. Affinity Exploration of SARS-CoV-2 RBD Variants to mAb-Functionalized Plasmonic Metasurfaces for Label-Free Immunoassay Boosting.
Li F; Hong J; Guan C; Chen K; Xie Y; Wu Q; Chen J; Deng B; Shen J; Liu X; Hu R; Zhang Y; Chen Y; Zhu J
ACS Nano; 2023 Feb; 17(4):3383-3393. PubMed ID: 36630157
[TBL] [Abstract][Full Text] [Related]
6. Epistasis at the SARS-CoV-2 Receptor-Binding Domain Interface and the Propitiously Boring Implications for Vaccine Escape.
Rochman ND; Faure G; Wolf YI; Freddolino PL; Zhang F; Koonin EV
mBio; 2022 Apr; 13(2):e0013522. PubMed ID: 35289643
[TBL] [Abstract][Full Text] [Related]
7. A novel consensus-based computational pipeline for screening of antibody therapeutics for efficacy against SARS-CoV-2 variants of concern including Omicron variant.
Kumar N; Kaushik R; Zhang KYJ; Uversky VN; Sahu U; Sood R; Bhatia S
Proteins; 2023 Jun; 91(6):798-806. PubMed ID: 36629264
[TBL] [Abstract][Full Text] [Related]
8. Wild-type SARS-CoV-2 neutralizing immunity decreases across variants and over time but correlates well with diagnostic testing.
O'Shea KM; Schuler CF; Chen J; Troost JP; Wong PT; Chen K; O'Shea DR; Peng W; Gherasim C; Manthei DM; Valdez R; Baldwin JL; Baker JR
Front Immunol; 2023; 14():1055429. PubMed ID: 36845123
[TBL] [Abstract][Full Text] [Related]
9. A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.
Zhang J; Han ZB; Liang Y; Zhang XF; Jin YQ; Du LF; Shao S; Wang H; Hou JW; Xu K; Lei W; Lei ZH; Liu ZM; Zhang J; Hou YN; Liu N; Shen FJ; Wu JJ; Zheng X; Li XY; Li X; Huang WJ; Wu GZ; Su JG; Li QM
Elife; 2022 Aug; 11():. PubMed ID: 36004719
[TBL] [Abstract][Full Text] [Related]
10. Neutralizing antibodies to SARS-CoV-2 variants of concern including Delta and Omicron in subjects receiving mRNA-1273, BNT162b2, and Ad26.COV2.S vaccines.
Zhang GF; Meng W; Chen L; Ding L; Feng J; Perez J; Ali A; Sun S; Liu Z; Huang Y; Guo H; Gao SJ
J Med Virol; 2022 Dec; 94(12):5678-5690. PubMed ID: 35902378
[TBL] [Abstract][Full Text] [Related]
11. Gold nanoparticle conjugate-based lateral flow immunoassay (LFIA) for rapid detection of RBD antigen of SARS-CoV-2 in clinical samples using a smartphone-based application.
Prakashan D; Shrikrishna NS; Byakodi M; Nagamani K; Gandhi S
J Med Virol; 2023 Jan; 95(1):e28416. PubMed ID: 36541714
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a rapid and easy-to-perform point-of-care lateral flow immunoassay (LFIA) for the detection of SARS-CoV-2 spike protein.
Mohammad S; Wang Y; Cordero J; Watson C; Molestina R; Rashid S; Bradford R
Front Immunol; 2023; 14():1111644. PubMed ID: 36911726
[TBL] [Abstract][Full Text] [Related]
13. Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike.
Changrob S; Fu Y; Guthmiller JJ; Halfmann PJ; Li L; Stamper CT; Dugan HL; Accola M; Rehrauer W; Zheng NY; Huang M; Wang J; Erickson SA; Utset HA; Graves HM; Amanat F; Sather DN; Krammer F; Kawaoka Y; Wilson PC
mBio; 2021 Dec; 12(6):e0297521. PubMed ID: 34781736
[TBL] [Abstract][Full Text] [Related]
14. Electrochemical biosensing platform based on hydrogen bonding for detection of the SARS-CoV-2 spike antibody.
Liv L; Yener M; Çoban G; Can ŞA
Anal Bioanal Chem; 2022 Jan; 414(3):1313-1322. PubMed ID: 34741650
[TBL] [Abstract][Full Text] [Related]
15. A novel delayed lateral flow immunoassay for enhanced detection of SARS-CoV-2 spike antigen.
Srithong P; Chaiyo S; Pasomsub E; Rengpipat S; Chailapakul O; Praphairaksit N
Mikrochim Acta; 2022 Sep; 189(10):386. PubMed ID: 36125616
[TBL] [Abstract][Full Text] [Related]
16. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
[TBL] [Abstract][Full Text] [Related]
17. Antibody cocktail effective against variants of SARS-CoV-2.
Liang KH; Chiang PY; Ko SH; Chou YC; Lu RM; Lin HT; Chen WY; Lin YL; Tao MH; Jan JT; Wu HC
J Biomed Sci; 2021 Nov; 28(1):80. PubMed ID: 34814920
[TBL] [Abstract][Full Text] [Related]
18. Potential of antibody pair targeting conserved antigenic sites in diagnosis of SARS-CoV-2 variants infection.
Wang S; Wu Y; Wang Y; Chen Z; Ying D; Lin X; Liu C; Lin M; Zhang J; Zhu Y; Guo S; Shang H; Chen X; Qiang H; Yin Y; Tang Z; Zheng Z; Xia N
J Virol Methods; 2022 Nov; 309():114597. PubMed ID: 35932997
[TBL] [Abstract][Full Text] [Related]
19. Equine Anti-SARS-CoV-2 Serum (ECIG) Binds to Mutated RBDs and N Proteins of Variants of Concern and Inhibits the Binding of RBDs to ACE-2 Receptor.
Andrade SA; Batalha-Carvalho JV; Curi R; Wen FH; Covas DT; Chudzinski-Tavassi AM; Moro AM
Front Immunol; 2022; 13():871874. PubMed ID: 35898497
[TBL] [Abstract][Full Text] [Related]
20. Proof-of-concept for speedy development of rapid and simple at-home method for potential diagnosis of early COVID-19 mutant infections using nanogold and aptamer.
Ellipilli S; Wang H; Lee WJ; Shu D; Guo P
Nanomedicine; 2022 Sep; 45():102590. PubMed ID: 35905841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
